"One of the conversations I heard in the hallway was, 'What's going to happen to my research, my data? This is data that [is ...

Ten drugs were classified as low or no added therapeutic benefit compared with alternatives, accounting for $6.7 billion in ...

The U.S. now has more than double the number of measles cases it saw in all of 2024, with Texas reporting another large jump ...